Cervical Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

The use of chimeric antigen receptor T-cell (CAR-T) therapy for hematologic malignancies is rapidly increasing, and appropriately managing adverse events (AEs) is crucial. Cytokine release syndrome (CRS) is a common AE of CAR-T therapy, characterized by systemic symptoms such as fever and respire-ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Yu, Fujino, Takahiro, Chinen, Shotaro, Niiyama-Uchibori, Yui, Ide, Daisuke, Kawata, Moe, Hashimoto, Keiko, Takimoto-Shimomura, Tomoko, Nakayama, Ai, Tsukamoto, Taku, Mizutani, Shinsuke, Shimura, Yuji, Hirano, Shigeru, Kuroda, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Otolaryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257532/
https://www.ncbi.nlm.nih.gov/pubmed/37303362
http://dx.doi.org/10.7759/cureus.38905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257532/
https://www.ncbi.nlm.nih.gov/pubmed/37303362
http://dx.doi.org/10.7759/cureus.38905

Ejemplares similares